dapsone has been researched along with Epilepsies, Partial in 1 studies
Epilepsies, Partial: Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. (From Adams et al., Principles of Neurology, 6th ed, pp317)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone has shown anti-convulsive properties in animal models of epilepsy." | 2.76 | Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial. ( Corona, T; Diaz-Ruiz, A; López-Gómez, M; Ríos, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Gómez, M | 1 |
| Corona, T | 1 |
| Diaz-Ruiz, A | 1 |
| Ríos, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia[NCT02575235] | Early Phase 1 | 100 participants (Actual) | Interventional | 2015-10-01 | Completed | ||
| Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia: An Exploratory Pilot Study[NCT02297997] | Early Phase 1 | 65 participants (Actual) | Interventional | 2014-11-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dapsone and Epilepsies, Partial
| Article | Year |
|---|---|
Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial.
Topics: Adolescent; Adult; Anticonvulsants; Dapsone; Drug Interactions; Electrocardiography; Epilepsies, Par | 2011 |
Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial.
Topics: Adolescent; Adult; Anticonvulsants; Dapsone; Drug Interactions; Electrocardiography; Epilepsies, Par | 2011 |
Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial.
Topics: Adolescent; Adult; Anticonvulsants; Dapsone; Drug Interactions; Electrocardiography; Epilepsies, Par | 2011 |
Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial.
Topics: Adolescent; Adult; Anticonvulsants; Dapsone; Drug Interactions; Electrocardiography; Epilepsies, Par | 2011 |